TMPRSS2 and prostate cancer: The most common chromosomal rearrangement in prostate cancer present in approx. 50% of patients results from the fusion of the androgen-regulated gene, transmembrane protease serine 2 gene (TMPRSS2, chr21q22.2), with E-twenty-six (ETS)-related gene (ERG, chr21q22.3).